Duality Advisers LP Buys New Stake in Encompass Health Co. (NYSE:EHC)

Duality Advisers LP purchased a new position in Encompass Health Co. (NYSE:EHC) during the 4th quarter, Holdings Channel reports. The institutional investor purchased 17,956 shares of the company’s stock, valued at approximately $1,198,000.

Other large investors have also made changes to their positions in the company. Treasurer of the State of North Carolina grew its stake in Encompass Health by 0.5% during the 3rd quarter. Treasurer of the State of North Carolina now owns 48,339 shares of the company’s stock worth $3,246,000 after buying an additional 231 shares during the last quarter. Handelsbanken Fonder AB raised its stake in Encompass Health by 1.9% in the fourth quarter. Handelsbanken Fonder AB now owns 15,953 shares of the company’s stock valued at $1,064,000 after buying an additional 300 shares during the last quarter. Personal CFO Solutions LLC boosted its holdings in Encompass Health by 5.2% in the third quarter. Personal CFO Solutions LLC now owns 6,231 shares of the company’s stock worth $419,000 after acquiring an additional 310 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of Encompass Health by 14.7% during the third quarter. EverSource Wealth Advisors LLC now owns 2,713 shares of the company’s stock worth $182,000 after acquiring an additional 347 shares during the last quarter. Finally, Verdence Capital Advisors LLC increased its holdings in shares of Encompass Health by 7.1% during the third quarter. Verdence Capital Advisors LLC now owns 5,580 shares of the company’s stock valued at $375,000 after acquiring an additional 370 shares in the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Stock Performance

Shares of EHC stock opened at $82.46 on Wednesday. Encompass Health Co. has a 52-week low of $57.55 and a 52-week high of $83.73. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.19. The stock has a market cap of $8.26 billion, a PE ratio of 23.76, a price-to-earnings-growth ratio of 1.49 and a beta of 0.94. The business has a 50-day simple moving average of $77.70 and a 200-day simple moving average of $70.59.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Wednesday, February 7th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $0.12. The company had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.24 billion. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. On average, equities analysts expect that Encompass Health Co. will post 3.96 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were issued a $0.15 dividend. The ex-dividend date was Thursday, March 28th. This represents a $0.60 dividend on an annualized basis and a yield of 0.73%. Encompass Health’s payout ratio is 17.29%.

Wall Street Analyst Weigh In

A number of research firms recently commented on EHC. Barclays lifted their target price on shares of Encompass Health from $95.00 to $101.00 and gave the stock an “overweight” rating in a research note on Thursday, March 28th. Stephens reiterated an “overweight” rating and set a $85.00 price objective on shares of Encompass Health in a research note on Tuesday, January 16th. William Blair reissued an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Truist Financial lifted their price target on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Finally, Mizuho boosted their price target on Encompass Health from $77.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, February 9th. Eight analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $83.22.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.